CDK4 and carcinoma: Of the proliferative factors analysed (PCNA, cyclin A, cyclin D, the cyclin-dependent kinases cdk2 and cdk4, cell cycle phases) only PCNA and cyclin A (CCNA) exhibited a relationship to sensitivity/resistance and were down-regulated in resistant carcinomas.